McKesson Corporation operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares McKesson with three other
drug stores in North America:
Cardinal Health, Inc.
(2018
sales of $136.81 billion
of which 89%
was Pharmaceutical),
CVS Health Corp
($194.58 billion
of which 69%
was Pharmacy Services Segment), and
AmerisourceBergen Corporation
($167.94 billion
of which 96%
was Pharmaceutical Distribution).
Sales Analysis.
McKesson reported sales of $208.36 billion
for the
fiscal
year ending
March of 2018.
This
represents
an
increase of 4.9%
versus 2017, when the company's sales were $198.53 billion.
Sales at McKesson have increased during each of the previous five years
(and since 2013, sales have increased a total of 70%).
Sales of Distribution Solutions saw an increase
of
6.2% in 2018, from
$195.92 billion to $208.12 billion.
Not all segments of McKesson experienced an increase in sales in 2018:
sales of Technology Solutions fell 90.8% to $240.00 million.
(However, this segment's sales were only a very small portion of the company's overall sales).